Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
€36,72 ↓ -1,56 (-4,08%)
2026-06-02
HİSSE FİYATI
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership692 shares
Latest Disclosed Value $ 25,431
Pinnacle Bancorp, Inc. reports 27.68% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 22, 2026 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 692 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $21,833 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 542 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 27.68% during the quarter. The current value of the position is $25,410 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F Novo Nordisk A ADR 670100205 692 150 27.68 25 -7.41 0.0075
2026-01-22 2025-12-31 13F Novo Nordisk A ADR 670100205 542 0 0.00 28 -10.00 0.0081
2025-10-24 2025-09-30 13F Novo Nordisk A ADR 670100205 542 0 0.00 30 -18.92 0.0089
2025-07-11 2025-06-30 13F Novo Nordisk A ADR 670100205 542 -400 -42.46 37 -43.08 0.0115
2025-04-23 2025-03-31 13F Novo Nordisk A ADR 670100205 942 -554 -37.03 65 -49.22 0.0213
2025-01-14 2024-12-31 13F Novo Nordisk A ADR 670100205 1,496 336 28.97 129 -7.25 0.0419
2024-10-09 2024-09-30 13F Novo Nordisk A ADR 670100205 1,160 118 11.32 138 -6.76 0.0369
2024-07-15 2024-06-30 13F Novo Nordisk A ADR 670100205 1,042 0 0.00 149 11.28 0.0439
2024-04-16 2024-03-31 13F Novo Nordisk A ADR 670100205 1,042 0 0.00 134 24.30 0.0396
2024-01-25 2023-12-31 13F Novo Nordisk A ADR 670100205 1,042 500 92.25 108 118.37 0.0353
2023-10-18 2023-09-30 13F Novo Nordisk A ADR 670100205 542 271 100.00 49 13.95 0.0175
2023-07-14 2023-06-30 13F Novo Nordisk A ADR 670100205 271 0 0.00 44 0.00 0.0150
2023-04-14 2023-03-31 13F Novo Nordisk A ADR 670100205 271 0 0.00 43 0.0158
2023-01-24 2022-12-31 13F Novo Nordisk A ADR 670100205 271 0 0.00 0 -100.00 0.0142
2022-10-25 2022-09-30 13F Novo Nordisk A ADR 670100205 271 -72 -20.99 27 -28.95 0.0117
2022-07-12 2022-06-30 13F Novo Nordisk A ADR 670100205 343 0 0.00 38 0.00 0.0156
2022-04-14 2022-03-31 13F Novo Nordisk A ADR 670100205 343 -16 -4.46 38 -5.00 0.0132
2022-01-19 2021-12-31 13F Novo Nordisk A ADR 670100205 359 0 0.00 40 17.65 0.0141
2021-10-12 2021-09-30 13F Novo Nordisk A ADR 670100205 359 55 18.09 34 36.00 0.0136
2021-07-15 2021-06-30 13F Novo Nordisk A ADR 670100205 304 0 0.00 25 25.00 0.0114
2021-04-26 2021-03-31 13F Novo Nordisk A ADR 670100205 304 -352 -53.66 20 -56.52 0.0097
2021-01-13 2020-12-31 13F Novo Nordisk A ADR 670100205 656 0 0.00 46 0.00 0.0283
2020-10-13 2020-09-30 13F Novo Nordisk A ADR 670100205 656 119 22.16 46 31.43 0.0324
2020-07-07 2020-06-30 13F Novo Nordisk A ADR 670100205 537 0 0.00 35 9.38 0.0260
2020-04-09 2020-03-31 13F Novo Nordisk A ADR 670100205 537 -400 -42.69 32 -40.74 0.0273
2020-01-10 2019-12-31 13F Novo Nordisk A ADR 670100205 937 -203 -17.81 54 -8.47 0.0374
2019-10-08 2019-09-30 13F Novo Nordisk A ADR 670100205 1,140 203 21.66 59 22.92 0.0337
2019-07-08 2019-06-30 13F Novo Nordisk A ADR 670100205 937 123 15.11 48 11.63 0.0270
2019-04-05 2019-03-31 13F Novo Nordisk A ADR 670100205 814 -50 -5.79 43 7.50 0.0249
2019-03-20 2018-12-31 13F Novo Nordisk A ADR 670100205 864 190 28.19 40 73.91 0.0246
2017-04-17 2017-03-31 13F Novo Nordisk A ADR 670100205 674 674 23 0.0163
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.